The tariff classification of blood glucose monitoring system from China
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated June 18, 2025, you requested a tariff classification ruling. Descriptive literature was provided for our review. The item under consideration is the iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+), which is a device that allows users to measure and track their blood glucose levels using a smartphone or tablet. It connects via Bluetooth and automatically records readings in the iGluco app, eliminating the need for manual logging.
The system simplifies blood sugar management by providing a connected way to monitor, store, and share data with healthcare providers or family members. The system includes the iHealth Wireless Smart Glucose Meter, iHealth Glucose Test Strips (EGS-2003), and the iHealth Gluco-Smart App (mobile application). This system is designed for use by individuals with diabetes to self-monitor blood glucose levels.
It utilizes an electrochemical measurement method, wherein a drop of fresh capillary whole blood is applied to the test strip, which reacts with glucose dehydrogenase. This reaction generates a small electric current that is measured by the glucose meter to determine the glucose concentration. The accompanying mobile application provides real-time tracking and data analysis for ongoing diabetes management.
The system can measure blood samples drawn from various body sites, including the fingertip, palm, forearm, upper arm, calf, or thigh, making it adaptable and convenient for users with mobility or dexterity challenges. General Rule of Interpretation (GRI) 1, Harmonized Tariff Schedule of the United States (HTSUS), states in part that for legal purposes, classification shall be determined according to the terms of the headings and any relative section or chapter notes.
Goods that are, prima facie, classifiable under two or more headings, are classifiable in accordance with GRI 3, HTSUS. GRI 3(a) states, in part, that when two or more headings each refer to part only of the items in a set put up for retail sale, those headings are to be regarded as equally specific, even if one heading gives a more precise description of the good. The instant goods consist of at least two different articles that are, prima facie, classifiable in different subheadings.
It consists of articles put up together to carry out a specific activity (i.e., blood glucose testing). Finally, the articles are put up in a manner suitable for sale directly to users without repacking.
Therefore, the goods in question are within the term “goods put up in sets for retail sale.” GRI 3(b) states, in part, that goods put up in sets for retail sale, which cannot be classified by reference to GRI 3(a), are to be classified as if they consisted of the component which gives them their essential character. It is the opinion of this office that the essential character of the iHealth Wireless Smart Gluco-Monitoring System (iHealth Gluco+) is imparted by the glucose meter.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N350393).